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Summary.-All of 10 patients with colonic carcinoma and 5 with malignant mela-
noma of skin showed no sign of immunoreactivity against the cultured tumour cells
by the lymphocyte populations residing within the tumours. More than half of these
patients did show cytotoxic reactivity by their bloodlymphocytes. Possible cytotoxic
reactivity by the regional lymph node lymphocytes was also investigated in 57
tumour cases (44 colonic, 13 melanoma, and including 12 of the 15 examined for
intrinsic lymphocyte activity). One third of the cases showed positive blood lympho-
cyte immunoreactivity, but in only 4 tumours (3 colonic) did the node lymphocytes
show any cytotoxicity against the tumour cells. This state of anergy of intrinsic and
regional lymphocytes is presumably acquired during the development of the cancer
and would permit local tumour spread and metastasis to lymph nodes. Its cause
has not been identified but appears to be lymphocyte inhibition rather than selective
change in lymphocyte population. In particular, no special pattern can be seen in the
relative proportions of T and B cells in patients' blood, lymph node or intrinsic
carcinoma lymphocytes.
IN earlier reports of immunological
reactivity in patients with carcinoma of
colon (Nairn et al., 1971a), and squamous
cell carcinoma and malignant melanoma
of skin (Nairn et al., 1971b, 1972; Nairn,
1972), we observed that lymphocytes from
the carcinoma itself or from regional
lymph nodes were not cytotoxic against
cultured tumour cells even though the
patients' blood lymphocytes often were
cytotoxic. Continued work has elaborated
these preliminary observations and we
have studied the phenomenon more deeply
by analysing and varying, by cell fraction-
ation procedures, the intrinsic lympho-
cyte populations of the carcinomata
before culture. T and B cell proportions
in the different lymphoid preparations
have been assessed by membrane immuno-
fluorescence and show no apparent corre-
lation with lymphocyte cytotoxicity.
MATERIALS AND METHODS
Tumour and blood collection, preparation
of cell suspensions, freeze storage, inhibition
ofmicrobial growth, and culture of carcinoma
cells for detecting cytotoxic activity of the
patient's lymphocytes were all performed by
the same techniques as in the earlier studies
cited above.
For the investigation of intrinsic lympho-
cyte reactivity, 10 cases of colonic carcinoma
and 5 of malignant melanoma of skin (2
metastatic) were selected only insofar as they
were the first tumours received providing
sufficient carcinoma cells and lymphocytes
for the investigations. For most tests, the
cells from the carcinoma wAere used fresh.
Frozen cells preserved with dimethylsulph-
oxide in liquid nitrogen were used only when
we were assured that this w%ould not interfere
with assessment of comparative tumour
growth in culture. For the testing ofpossible
interaction between intrinsic lymphocytes
and blood or lymph node lymphocytes, the
majority of blood and lymph node prepara-
tions were also used fresh for culture; only 1
lymphocyte specimen from blood and 3 from
lymph node, all colonic cases, were freeze
stored before use. The lymph nodes and
blood lymphocytes were obtained about the
time of operation, except for Case 6 in whichLYMPHOCYTE ANERGY IN PATIENTS WITH CARCINOMA
blood lymphocytes were obtained 6 and 10
weeks later.
For the investigation of regional lymph
node lymphocyte reactivity, 57 tumours
were examined: 44 were colonic carcinomata
(1 metastatic in liver) and 13 skin melano-
mata (4 metastatic in lymph node, 2 in brain),
including all the cases in Table I except 3, 14.
15. In 31 cases, the lymphocytes were used
fresh wvithout prior freezing and the majority
of the parallel blood lymphocyte cytotoxicity
studies were also made with fresh cells
(frozen-thawed blood lymphocytes were used
in 11 colonic cases only). In 5 cases, the fresh
blood lymphocytes were not available until
some weeks after the operation but none were
used beyond 20 weeks. Persistence of the
patient's lymphocyte reactivity for several
months after tumour resection has been
established in our earlier and present
studies. We were unable to test blood
lymphocyte reactivity in 6 of the colonic
carcinomata.
Spleen cell reactivity was investigated in
3 cases. Two were post mortem melanomata
(12b, 13) and one a metastatic colonic carci-
noma in liver (72/158-Table III).
Tumour cell fractionation to alter intrinsic
lymphocytosis-.For this investigation, the 15
tumour cell suspensions plus 3 additional
preparations from further specimens of 2 of
the melanoma cases (11 and 12-Table I)
were passed successively through and eluted
from 2 sterile glass bead columns (modified
from Shortman, 1966) to change the propor-
tion of lymphocytes to carcinoma cells in the
effluents. Samples of each effluent were
kept for culture and wherever possible for
T and B lymphocyte analysis.
The columns were made from 5 ml
plastic syringe barrels with the nozzle lightly
plugged with glass wool and fitted with a
No. 22 Luer hypodermic needle; they con-
tained 2 ml of glass beads of 60-90 ,um
diameter.
The original tumour cell suspension was
gently washed 3 times in medium 199
containing 10bo foetal calf serum with centri-
fuging at 250 g maximum for 5 min periods.
It was adjusted to a concentration of 3-10
million cells per ml, and 5 ml of this sus-
pension was passed through a glass bead
column previously rinsed with medium 199
containing 10% foetal calf serum: this
yielded fraction 1. The beads were then
removed from the column and rinsed twice
with 10 ml of the same medium to give frac-
tion 2. Of this, 15-25 million cells were
recovered by centrifuging and resuspended
in 5 ml medium 199 containing 5000, foetal
calf serum and passed through a column
previouslv rinsed Mwith the same solution.
This yielded fraction 3, and two 10 ml
washings ofthe beads with the same medium,
fraction 4. The viability of lymphocytes
obtained in each fraction wNas always above
5000, as judged by exclusion of 0-10/O trypan
blue dye.
Lymphocyte preparationsfrom blood, lymph
node and spleen.-Blood lymphocytes were
separated routinely for cytotoxicity tests by
allowing heparinized blood to settle, and
washing the buffy layer ofleucocytes through
a glass wool column with medium 199 con-
taining 10% foetal calf serum. When pre-
pared in this simple way, there was a small
contamination by up to 10% granulocytes
but accurate immunoglobulin-negative and
-positive lymphocyte (respectively regarded
here T and B cell) counts could usually be
made without difficulty. In order to confirm
this, many comparative counts were also
made on blood lymphocyte preparations of
greater purity obtained by more stringent
separation procedures with glass beads or
glass wool and Hypaque-Ficoll sedimentation
of whole blood (e.g., Yamana, Rolland and
Nairn, 1973).
Lymph node lymphocytes and spleen cells
were obtained in suspension by gentle
mechanical teasing in medium 199 containing
10% foetal calf serum.
Assay of T and B lymphocytes-.This was
by membrane immunofluorescence (Papami-
chail, Brown and Holborow, 1971). Fresh
or frozen-thawed lymphocyte suspensions
were treated with fluorescein-conjugated
anti-human-globulin. This had activity
against IgG, IgM and IgA, and a fluorescein
to protein molar ratio of 49 1. It was
absorbed with bovine liver and human group
AB erythrocytes, and when used at a globulin
concentration of 0-400 gave no fluorescent
staining of T cells, as represented by infant
thymocytes in preliminary studies. With
this reagent, B cells gave bright membrane
immunofluoreseence; some lymphoid cells
from tumour or lymph node gave solid cyto-
plasmic staining and were counted as B cells
producing antibody.
Lymphocytes, numbering 100-200, were
counted in each stained preparation, the B
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cells were enumerated and the T cells assessed
by difference. Accurate countingnecessitated
the recognition and ignoring ofnon-lymphoid
cells usually unstained but occasionally
stained nonspecifically, as in the case of
granulocytes. These were largely removed
from blood and fractionated carcinoma by
their adherence to the glass w-ool and beads
to which th-ey were respectively exposed;
unfractionated carcinoma cell suspensions
contained only a few granulocytes and the
lymplh node preparations virtually none.
The validity of our blood lymphocyte
separation and discrimination by simple
glass wool filtration was established by the
comparisons w%vith the alternative procedures
already referred to. The cell populations of
all specimens were confirmed morphologically
by phase-contrast microscopy and identifi-
cation of lymphocytes corresponded with
immunofluorescent staining by specific anti-
lymphocyte globulin.
Lymtphocyte reactivity against tumour irn
culture.-Tumour cell suspensions were cul-
tured, wvith or wvithout test lymphocytes, in
Teflon ring chambers mounted on standard
miicroseope slides as in our earlier investiga-
tions already cited. The original tumour cell
stuspension (3 x 105 cells in 0-6 ml culture
medium 199 and 1000 foetal calf serum plus
0-1 ml human blood group AB serum rich
in complement) with its intrinsic lymphocyte
population wvas cultured alone and with
added test lymphocytes (6 x 105) from
patient's blood, lymph node or spleen, or as
controls with homologous lymphocytes. Be-
cause the tumour cell suspensions contained
a small proportion of stromal cells, the final
ratio of added lymphocytes per tumour cell
was approximately 2-5: 1. The 4 tumour
cell suspension fractions were similarly
cultured in some experiments with added
blood or lymph node lymphocytes from the
patient. In a few experiments, cytotoxic
lymphocytes were removed from larger
culture chambers, purified by filtration
through glass wool and retested in standard
chambers in the same proportions against
new tumour cells.
For cytotoxicity testing, the culture cham-
ber wvas first incubated with coverglass down
for 2 days and then inverted to facilitate
growth ofa monolayer on the coverglass, now
uppermost, free from dead cells and debris
w%Nhich sink to the bottom of the chamber.
Growth of tumour cells on the cover-
glasses of triplicate culture clhambeirs was
assessed microscopically after 5 days (Nairn
et al., 1971a) as the percentage area occupied
by viable tumour cells, to the neaiest 1000.
In the absence of cytotoxic effect, the mono-
layer covered 50-1000o, of the coverglass
within this period. Mean values of the
replicates, for test and control cultures, read
blind, wAere compared in every experiment
and a difference of over 200/ was required
for significant cytotoxicity assessmenit (Table
II). With this test system, estimating
lymphocytotoxicity is mostly an all or
none "1 observation, since in the vast majority
ofexperiments w%,herecytotoxicity wasdemon-
strated the test cultures showed virtually Ino
viable cancer cells on the coverglasses as
opposed to a 50-100O0 area coverage in the
normal control cultures. In Table I, mean
values for triplicate cultures of the origiinal
tumour suspension and its fractions are
given. Variation between replicates in all
experiments were small, hardly ever greater
than Io/ area.
RESULTS
Intrinsic lymphocytes
Varying the intrinsiclymphocyte popu-
lation of the different tumour fractions
had no significant effect on tumour cell
proliferation (Table I). The variations in
growth that occurred were not consistentlv
correlated with the lymphocyte numbers
or T and B cell proportions. The propor-
tion of lymphocytes in the cultures in all
but 2'cases (Ila and 15) was lower than
the 70%0 routinely employed for blood
lymphocyte cytotoxicity testing although
it would be reasonable to expect that suich
intrinsic lymphocytes might include a
larger proportion specifically immune to
the tumour.
Blood lymphocyte reactivity with
tumour fractions (Table II) was tested in
4 colonic carcinomata (Cases 4, 6, 7, 8)
and 2 specimens of I melanoma (Case 12a,
b). In Cases 4, 7 and 8, tests were made
only against the original tumour and
fraction 1, whereas in the others all
fractions were tested. The variation in
lymphocyte population hadl Ino effect oni
the reactivity ofeither positive or- negative
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TABLE II.-Effect ofPatients' Lymphocytes on Tumour Growth
With patients' lymphocytes
Ditn
Case or Record No.
Ca Colon1
72/111
6*
6 (Fraction I)
6 (Fraction 2)
6 (Fraction 3)
6 (Fraction 4)
72/158
1
2
4
4 (Fraction 1)
4 (Fraction 2)
4 (Fraction 3)
4 (Fraction 4)
5
70/80
72/81
72/92
72/109
72/125
3
7
7 (Fraction 1)
8
8 (Fraction 1)
9
10
71/137
72/9
72/13
72/14
72/15
72/16
72/20
72/22
72/23
72/25
72/26
72/29
72/48
72/52
72/61
72/94
72/102
72/118
72/119
72/137
72/139
72/154
71/20
71/139
72/38
72/82
72/121
72/150
Tumour
alone
50
30
30
30
30
30
60
40
50
50
60
60
60
30
20
90
50
40
30
30
30
40
30
40
40
50
30
50
70
30
50
20
20
30
60
20
70
50
50
40
20
40
30
20
30
20
30
40
60
80
70
30
50
20
60
Regional
Bloodt lymph node
<10 30
40* 10
50 -
40
50
50
60 40
20 50
30 60
< 10 50
<10 70
70
50
30
0 20
10 90
<10(<10) 40
<10 40
10 40
<10 30
< 10
40 30
30 30
50 50
60
60 60
40 30
50 50
70 (70) 70
20 30
50 50
30 30
20 20
40 30
60 50
20 20
60 60
50 50
60 (60) 50
50 (40) 50
30 30
50 40
30 30
40 20
40 30
20 20
30 30
30 30
60 60
70
70
- 20
50
20
70
Distant
lymph node
40
40
30
30
30
30
80
20
70
With
homologous
Spleeni lymphocytes
- 50
40
_ tS~~0
- 30
- ~~50
- 50
20 60
40
-- 60
50
70
20
- 100
50
40
40
30
- 30
40
30
50
40
60
30
50
70
20
20
- 60
20
60
-50
40
30
40
30
20
30
20
30
40
50
80
20
50
20
70
Jllalignant Melanonta
Ila
Ila (FrIactioni 1)
1I b
IIb (Fractiorn 2)
12a
30
30
60
(60
40
<10
20
< 10
10
10
40
30
60
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TABLE II.--(continued)
With patients' lymphocytes
Wuith Tumour Regional Distant homologous Case or Record No. alone Bloodt lymph node lymph node Spleen lymphocytes
12a (Fraction 1) 40 <10 70
12a (Fractioi 2') 40 10 70
12a (Fraction 3) 50 <10 70
12a (Fraction 4) 30 < 10
12b 40 10 50 40 50 50 12b (Fraction 1) 40 20 50
12b (Fraction 2) 30 10 50
12b (Fraction 3) 30 10 50
12b (Fraction 4) 30 10 50
13 30 < 10 40 40 40 40
71/59 90 50 90 10(
72/96 50 < 10 (<10) 50 50
71/133 90 50 9( - 90
71/31 90 9( 9()0 9(
71/67 70 70 70 80
71/117 80 70 70 80
71/125 70 80 70 70
70/96 50( 50 5( 5( 72/93 20 30 30 30 72/34 30 30 (30) 30 30
Figures indicate percentage area of culture chamber coverglass occulpied by cancer cells.
t Figures in brackets indicate tumour growth obtained after addition of blood and lymph iode lympho- cytes together.
* Case 6 blood lymphocytes became positive (< 10) 10 weeks post-operatioii.
blood lymphocytes. Six tests were made
with non-cross-reacting homologous lym-
phocytes against colonic carcinoma (4)
and melanoma (2) fractions without any
change in reactivity.
Lymph node lymphocyte reactivity
with tumour fractions (Table II) was
tested in 2 colonic carcinomata (Cases 4, 7)
and 2 specimens of 1 melanoma (lla,b).
In Case 4, all fractions were tested, in 7
and 11a only fraction 1, and in 11b fraction
2. Reactivity against the colonic carci-
nomata was negative and unchanged with
the fractions; against the melanoma
specimens it was positive and also un-
changed with the fractions.
Lymph node lymphocytes
Only 4 of the 57 tumours examined
showed reactivity by the regional lymph
node lymphocytes (Table II): 3 were
colonic including I liver metastasis (Cases
6, 72/111, 72/158) and 1 a melanoma
(Case I1). The blood lymphocvtes at the
same lymphocyte to tumour cell ratio in
the cultures (2.5: 1) showed positive
cytotoxicity in 17 of the 51 cases in which
satisfactorv tests were possible. Of the 4
positive node lymphocyte cytotoxicitv
experiments, Case 6 was at first blood
lymphocyte-negative but became positive
with a repeat blood specimen 4 weeks
later, Case 11 was positive in repeated
tests; Case 72/111 was also positive and
Case 72/158 negative. The positive blood
lymphocyte reactivity was always stronger
than that of the node lymphocytes.
Six experiments were performed to
investigate possible interaction between
lymph node and blood lymphocytes (Table
II): 4 were with colonic carcinomata and
2 melanomata, none being from the cases
recorded in Table I. One of the colonic
and 1 melanoma case were blood lympho-
cyte-positive; they were all lymph node
lymphocyte-negative. For these tests,
the blood and lymph node lymphocytes
were added to the tumour culture cham-
bers in equal numbers to give the usual
lymphocyte to tumour cell ratio of 2-5: 1.
There was no sign of any effect by lymph
node lymphocytes on the alreadv known
blood lymphocyte reactivity.
In 11 of the cases (9 colonic), lymph
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nodes distant from the tumour were also
examined (Table II). The lymphocytes
were tested fresh except in 4 of the colonic
carcinomata where they were frozen-
thawed. Both of the melanoma cases and
1 colonic were blood lymphocyte-positive;
another colonic carcinoma (Case 6) was
blood lymphocyte-positive later and had
positive regional (near) node lymphocyte
reactivity. Blood and regional node
lymphocyte reactivities were negative in
the other cases. In all 11 cases, the distant
node lymphocytes were non-reactive.
T and 13 cell counts were made on 25
of the regional lymph nodes, on 16 of the
associated tumours and on 1 2 of the
relevant blood samples and 7 ofthe distant
nodes. The findings in the 1 6 cases in
which both regional lymph node and
tumour were examined are summarized in
Table III. It will be seen that except in
TABLE III. B Lymphocyte Proportions in
Blood, Regional Lymph Node and Tumour
Blood
Case or lympho-
Record Ino. cytotoxicity
(Ca Colonl
72/111 Cytotoxic
6 Cytotoxic (late:
I Cytotoxic
2 Cytotoxic
72/125 Cytotoxic
72/158 Non-cytotoxic
7 Non-eytotoxic
72/139 Noin-eytotoxic
72/I 18 Non-eytotoxic
72/48 Non-eytotoxic
10 Non-cytotoxic
Jllelanomia
11
13
I2b
72/96
721/93
B cells %
Lymph
Blood node Tumouir
,r)
Cyt,otoxic
Cytotoxic
Cytotoxic
Cytotoxic
Non-cytotoxic
26 36t
1 (later) 19t
7 39}
12 2.5
22 42
2 13t
2 32
26 30
36
85*
26 32
18
26
31
38t
52
52
2(0
21*
13*
51*
29
43*
64*
22*
33*
32*
8*
31*
16 (a,b)
47
28
14
* Includes maniy cells with cytoplasmic antibody.
t Lymphocytotoxic-positive.
UTneouintable because of confusion by pre-
existing globulin-binding to tuimour cells.
the tumour itself; the node count was
commonly a little higher than the tumour.
Solid cytoplasmic immunofluorescent
staining cells, considered to be antibody
forming, were found only among the
intrinsic lymphocytes of the colonic carci-
nomata except for 1 regional node (Case
72/48) which showed a verv high B cell
count (850% of total lymphocytes); the
blood lymphocyte count is not available
from this case. The abundance of anti-
body forming cells in the colonic tumours
is probably attributable to their greater
exposure to infection. The blood B
lymphocyte counts were frequently out-
side our normal range (8-24%) obtained
with the present technique on 10 normal
individuals. This wider variation of T
and B cell counts is presumably largely
attributable to patients' immunological
reactivities to the tumour itself, its
necrotic products, or its microbial conta-
minants.
Spleen cells
Tumourcytotoxicitystudieswere made
on spleen cell suspensions (Table II) in the
2 post mortem melanoma cases (I2b, 13)
both examined within 10 hours of death:
results were negative despite the post
mortem bloodlymphocytesbeing cytotoxic
to tumour cells. Their failure to react may
not necessarily reflect their cytotoxic
capability during life, because of possible
selective death of immune cells imme-
diately post mortem. A third case
(72/158) of metastatic liver tumour from
aprimary colonic carcinoma, tested against
spleen cells obtained during life, showed
strong cytotoxicity, hepatic lymph node
lymphocytes less cytotoxicity, and the
blood lymphocytes were non-reactive.
B cell counts on the 3 spleens were
unremarkable, being respectively 22, 37
and 23%.
I case of melanoma (I 2b), the B lympho-
cvte cotunlt in the blood was lower than in
the regional node and, except for 2 lymph
nlode-positive cases (72/11 1, II), than in
Cytotoxic lymphocytes re-reacted on new
tumomr cells
Preliminary studies to assess whetlher
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cells retain any reactivity after 5 davs'
cultivation with tumour were made in 2
melanoma cases (12a, 72/136) and I
colonic case (72/158). The larger original
culture chambers with the usual cell
proportions yielded sufficient supernatant
for a second tumour cytotoxicity test by
the routine procedure, but there was no
remaining cytotoxicity by the re-used
lymphocytes.
In1mmunopathological correlation
No correlation has been observed
between lymphocyte reactivity against the
tumours and their histopathological differ-
entiation ordissemination orthe immediate
prognosis of the patients. The short-term
fate has been followed in 42 patients
including 37 colonic carcinomata aind 5
melanomata. Death has occurred within
6 months from operation in all of 3 blood
lymphocyte-positive resected melanoma
patients, including I lymph node-positive.
Of the colonic carcinoma patients, I of
10 blood lymphocyte-positive, 4 of 27
blood lymphocyte-negative, including 1
lymph node-positive, were dead within 8
months from operation.
On the other hand, blood and lymph
nio(le lymphocyte reactivities have been
associated to some extent with particular
lymphoid histological patterns in tumour
anid lYmph node respectively. Twenty of
25 blood lymphocyte-negative colonic
cases showed a diffuse stromal leucocytic
infiltration of the tumours including large
lymphocytes and plasma cells associated
with eosinophil granulocytes. This type
of infiltration was found in only 4 of 8
lymphocyte-positive cases, which instead
showed a tendency to discrete perivascular
aggregation of small hyperchromatic lym-
phocytes. Such aggregates were the sole
type of reaction in 2 of the positive cases
and were never conspicuous in the negative
cases. The 3 positive lymph nodes from
colonic carcinomata all showed, histolo-
gically, a diffuse increase of small lym-
phocytes with follicular hypoplasia and
inconspicuous or absent germinal centres.
This pattern was not observed in any of
36 lymphocyte-negative lymph nodes ex-
amined: in these there was only non-
descript follicular and/orsinushyperplasia.
No notable histological features were
recognized in the 3 spleens.
DISCUSSION
Wre have observed no material in vitro
cytotoxic activity against colonic carci-
nomata or melanomata by their intrinsic
lymphocyte populations. Moreover, in
only 4 regional nodes of 57 cases examined
was weak lymphocyte reactivity demon-
strated. In contrast, there was an overall
positive blood lymphocyte reactivity in a
third of cases. Local lymph node lym-
phocyte anergy has also been reported in
human tumours by DiSaia et al. (1971)
and la'nky and Stjernsward (1971), but
we have seen no systematic stuidy of the
phenomenon. The timing of the anergy
is in doubt, but experimental studies in
this laboratory on a rat squamous cell
carcinoma (Flannery et al., 1973) showe(d
that regional nodes are immunoreactive
for some weeks and then become non-
reactive. Landazuri and Herberman
(1972) also report a waxing and waning of
lymphocyte cytotoxicity in a rat virus
lymphoma system.
The maintainance ofblood lymphocyte
cytotoxicity and the source of the effector
cells are further problems for study.
Among the possible tissue sites of anti-
tumour lymphocyte proliferation are the
tumour stroma, lymph nodes, spleen or
bone marrow. Only the last has not been
examined at all in this study, and although
current immunological theory makes it an
unlikely source of cytotoxic lymphocytes,
it deserves investigation. More likely
sources ofthe cytotoxic bloodlymphocytes
are the local, intrinsic, regional lymph
node and perhaps spleen populations,
despite their frequent anergy at the time
of testing. In support are our observa-
tions that positive blood lymphocyte
cytotoxicity is correlated histopatholo-
gically with tumour infiltration by discrete
aggregatesofsmalllymphocytes, that some
regional nodes contain reactive lympho-
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cytes and that 1 case had reactive spleen
cells.
Tumour infiltration by lymphocytes
has been reported as a favourable prog-
nostic feature in breast (Hamlin, 1968)
and melanoma (Thompson, 1972) though
other studies have failed to observe any
such correlation (Williams and Roberts,
1968; Little, 1972). Whatever effect
there might be on prognosis, it cannot be
great, and would perhaps reflect an active
state of the infiltrating lymphocytes at an
earlier stage before the anergy reported
here had developed.
It may be speculated that resident
lymphocytes within the tumour and the
local lymph nodes become inactivated in
some way to be determined, while those
that escape the local environment and
reach the circulation retain or regain
their specific tumour cytotoxicity. Could
this be lymphocyte washing by circulation
in non-inhibiting serum (cf. Currie and
Basham, 1972)? However, 1 of our
colonic cases (72/158) was blood lym-
phocyte-negative at a time when the
lymph node was positive. We found no
sign of collaboration of local lymphocytes
with blood lymphocytes, which would
seem to make untenable one explanation
of regaining of cytotoxicity by any such
lymphocyte collaboration. Another theo-
retical explanation of our findings, namely
a failure of immunoglobulin-positive and
-negative ("B and T") lymphocyte colla-
boration by variation in their proportions
at local sites, is supported by the observa-
tion that T cells are usually more numer-
rous in the blood, but we have examples of
high T cell (low B cell) counts in the
instrinsic tumour or regional lymph node
lymphocytes without evidence of tumour
cytotoxicity.
The possibility must be considered
that local killer lymphocytes may thein-
selves be destroyed or lose their killer
potentiality on contact with the tumour
or its antigens, leaving immunoreactive
only those which escape to the blood.
Our failure to detect any recycling of
lymphocyte cytotoxicity in the 3 repeat
cultures studied of used lymphocytes
against fresh tumour cells favours this.
However, these experiments are too few
for ready acceptance; indeed the occur-
rence of such lymphocyte recycling has
been reported in an experimental system
by Berke, Sullivan and Amos (1972).
Specific blocking of in vitro lympho-
cyte cytotoxic attack on human cells by
the serum of cancer patients (Hellstrom
et al., 1971) may be mediateJ by antigen-
antibody complexes (Sjogren et al., 1972),
probably reacting primarilywithsensitized
lymphocytes (Currie and Basham, 1972).
Blocking reactivity of sera from our cases
has not yet been investigated, but detec-
tion of antibodies against tumour cell
membrane and cytoplasm (Rolland et al.,
to be published) correlated poorly with
lymphocyte cytotoxicity. Studies on an
experimental animal tumour system in
our laboratories have demonstrated in-
hibitory activity in sera from animals
bearing advanced tumours at a time when
regional lymph nodes were anergic despite
persistent blood and spleen lymphocyte
cytotoxicity (Flannery et al., 1973). This
is presumably due to prolonged exposure
of local lymphocytes to relatively high
concentrations of soluble antigen, causing
a specific immunological paralysis (Alex-
ander, 1970; Baldwin, Price and Robins,
1972).
WNThatever the cause of the local lym-
phocyte anergy, the phenomenon is pre-
sumably highly significant biologically
and may be the explanation of tumour
spread and regional metastasis despite
local abundance of lymphocytes. It will
be of great interest to examine, wherever
clinically permissible, lymph nodes from
the tumour drainage area some months
after tumour resection to see ifthe anergic
state may be reversed.
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